The Open Source COVID-19 (OSC-19) research consortium is merging computer science and biochemistry to quickly, cheaply screen millions of possible drug molecules against COVID-19. The focus of the OSC-19 program is on drugs that are already approved for clinical use.
That way, the possible drugs identified by OSC-19 won’t have unexpected, dangerous side effects. Unacceptable side effects are an outcome that slows down drug screening in bench work. By reducing the risk of dangerous side effects, and using computer science to minimize bench work, OSC-19 will help bring COVID-19 therapies to the public as quickly as possible.